This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n14http://linked.opendata.cz/resource/drugbank/drug/DB08023/identifier/pdb/
n11http://linked.opendata.cz/resource/drugbank/drug/DB08023/identifier/pubchem-compound/
n7http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n12http://linked.opendata.cz/resource/drugbank/drug/DB08023/identifier/pubchem-substance/
n13http://linked.opendata.cz/resource/drugbank/drug/DB08023/identifier/drugbank/
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n10http://linked.opendata.cz/resource/drugbank/drug/DB08023/identifier/chemspider/

Statements

Subject Item
n2:DB08023
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB08023 n7:DB08023
dcterms:title
N-cyclohexyl-4-imidazo[1,2-a]pyridin-3-yl-N-methylpyrimidin-2-amine
adms:identifier
n10:22377450 n11:24801862 n12:99444494 n13:DB08023 n14:JNF
n3:IUPAC-Name
n4:271B5663-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5669-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5668-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5665-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5666-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5667-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5661-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5662-363D-11E5-9242-09173F13E4C5 n4:271B565F-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5660-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B566F-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5670-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B566A-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B566B-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B566D-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B566C-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B566E-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5674-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5676-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5677-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5673-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5672-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5675-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5664-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5671-363D-11E5-9242-09173F13E4C5